EROL, N. Et Al. 2012. Vision, Retinal Thickness, and Foveal Avascular Zone Size After Intravitreal Bevacizumab for Diabetic Macular Edema. ADVANCES IN THERAPY , vol.29, no.4 , 359-369.

EROL, N., Gursoy, H. H., Kimyon, S., Topbas, S., & ÇOLAK, E., (2012). Vision, Retinal Thickness, and Foveal Avascular Zone Size After Intravitreal Bevacizumab for Diabetic Macular Edema. ADVANCES IN THERAPY , vol.29, no.4, 359-369.

EROL, NAZMİYE Et Al. "Vision, Retinal Thickness, and Foveal Avascular Zone Size After Intravitreal Bevacizumab for Diabetic Macular Edema," ADVANCES IN THERAPY , vol.29, no.4, 359-369, 2012

EROL, NAZMİYE Et Al. "Vision, Retinal Thickness, and Foveal Avascular Zone Size After Intravitreal Bevacizumab for Diabetic Macular Edema." ADVANCES IN THERAPY , vol.29, no.4, pp.359-369, 2012

EROL, N. Et Al. (2012) . "Vision, Retinal Thickness, and Foveal Avascular Zone Size After Intravitreal Bevacizumab for Diabetic Macular Edema." ADVANCES IN THERAPY , vol.29, no.4, pp.359-369.

@article{article, author={NAZMİYE EROL Et Al. }, title={Vision, Retinal Thickness, and Foveal Avascular Zone Size After Intravitreal Bevacizumab for Diabetic Macular Edema}, journal={ADVANCES IN THERAPY}, year=2012, pages={359-369} }